|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
26
|
|
pubmed:dateCreated |
2005-6-30
|
|
pubmed:abstractText |
Intravenous bolus fluorouracil plus leucovorin is the standard adjuvant treatment for colon cancer. The oral fluoropyrimidine capecitabine is an established alternative to bolus fluorouracil plus leucovorin as first-line treatment for metastatic colorectal cancer. We evaluated capecitabine in the adjuvant setting.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:AbtMarkusM,
pubmed-author:BurrisHowardH3rd,
pubmed-author:CarratoAlfredoA,
pubmed-author:CassidyJimJ,
pubmed-author:CervantesAndrésA,
pubmed-author:FagerbergJanJ,
pubmed-author:GeorgouliasVassilisV,
pubmed-author:HusseiniFaresF,
pubmed-author:JodrellDuncanD,
pubmed-author:KoralewskiPiotrP,
pubmed-author:KröningHendrikH,
pubmed-author:MarounJeanJ,
pubmed-author:MarschnerNorbertN,
pubmed-author:McKendrickJosephJ,
pubmed-author:NowackiMarek PMP,
pubmed-author:PawlickiMarekM,
pubmed-author:RossoRiccardoR,
pubmed-author:SchüllerJohannesJ,
pubmed-author:ScheithauerWernerW,
pubmed-author:SeitzJean-FrançoisJF,
pubmed-author:StabucBorutB,
pubmed-author:TujakowskiJerzyJ,
pubmed-author:TwelvesChrisC,
pubmed-author:Van HazelGuyG,
pubmed-author:WongAlfredA,
pubmed-author:ZaluskiJerzyJ
|
|
pubmed:copyrightInfo |
Copyright 2005 Massachusetts Medical Society.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
30
|
|
pubmed:volume |
352
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2696-704
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15987918-Adult,
pubmed-meshheading:15987918-Aged,
pubmed-meshheading:15987918-Aged, 80 and over,
pubmed-meshheading:15987918-Antimetabolites, Antineoplastic,
pubmed-meshheading:15987918-Chemotherapy, Adjuvant,
pubmed-meshheading:15987918-Colonic Neoplasms,
pubmed-meshheading:15987918-Deoxycytidine,
pubmed-meshheading:15987918-Disease-Free Survival,
pubmed-meshheading:15987918-Female,
pubmed-meshheading:15987918-Fluorouracil,
pubmed-meshheading:15987918-Humans,
pubmed-meshheading:15987918-Male,
pubmed-meshheading:15987918-Middle Aged,
pubmed-meshheading:15987918-Multivariate Analysis,
pubmed-meshheading:15987918-Neoplasm Staging,
pubmed-meshheading:15987918-Survival Analysis
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Capecitabine as adjuvant treatment for stage III colon cancer.
|
|
pubmed:affiliation |
University of Leeds and Bradford NHS Hospitals' Trust, Leeds, United Kingdom. c.twelves@bradford.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
